- Published on
Pathology - Extrahepatic bile duct carcinoma
Definition: A malignant epithelial tumor that develops in an extrahepatic bile duct.
Epidemiology • Incidence is rare and does not vary by geography. Aetiology • PSC. • Infestation of liver fluke. • Choledochal cysts. 2 Choledocholithiasis doesn't appear to be important. Carcinogenesis • Mutations in KRAS and TP53 are identified.
Presentation: • Obstructive jaundice. • Fever and rigors can be caused by superimposed cholangitis. Macroscopy reveals a tumor in the bile duct, which can be polypoid, stenosing, or diffusely infiltrative.
Histopathology: • The majority of adenocarcinomas are well or moderately differentiated, with malignant epithelial cells forming glandular structures similar to bile ducts.
Prognosis: Patients with resectable tumors and clear surgical margins typically have a 5-year survival rate of 20-40%. • Tumors associated with PSC have a low 5-year survival rate (<10%).< />pan>
Definition: A malignant epithelial tumor that develops in an extrahepatic bile duct.
Epidemiology • Incidence is rare and does not vary by geography. Aetiology • PSC. • Infestation of liver fluke. • Choledochal cysts. 2 Choledocholithiasis doesn't appear to be important. Carcinogenesis • Mutations in KRAS and TP53 are identified.
Presentation: • Obstructive jaundice. • Fever and rigors can be caused by superimposed cholangitis. Macroscopy reveals a tumor in the bile duct, which can be polypoid, stenosing, or diffusely infiltrative.
Histopathology: • The majority of adenocarcinomas are well or moderately differentiated, with malignant epithelial cells forming glandular structures similar to bile ducts.
Prognosis: Patients with resectable tumors and clear surgical margins typically have a 5-year survival rate of 20-40%. • Tumors associated with PSC have a low 5-year survival rate (<10%).< />pan>
- Published on
Pathology – Cholecystitis
Cholecystitis is defined as gallbladder inflammation.
Epidemiology: • Very prevalent. Aetiology • The most common cause is gallstones (calculous cholecystitis). • Acalculous cholecystitis is also seen, particularly in the elderly.
Pathogenesis • Chemical harm to the mucosa by bile is thought to be the cause of biliary stasis. • A gallstone or inadequate gallbladder motility might block the gallbladder exit. Biliary colic causes acute upper abdomen pain that disappears spontaneously after several hours. • Acute cholecystitis is a serious condition characterized by persistent upper abdominal pain, fever, and tachycardia. Macroscopy reveals thicker gallbladder walls and potentially friable mucosa. • Gallstones are often present.
Histopathology • Acute cholecystitis is characterized by oedema, inflammatory cells, and granulation tissue. • Chronic cholecystitis is characterized by muscular hypertrophy and fibrous tissue, mild chronic inflammation, and the development of mucosal diverticula that herniate through the muscular layer (Rokitansky-Aschoff sinuses). • Xanthogranulomatous cholecystitis is a type of chronic cholecystitis characterized by the presence of macrophages and fibroblasts, likely due to a ruptured Rokitansky-Aschoff sinus.
Prognosis: Most individuals with calculous cholecystitis can be treated with cholecystectomy.
Cholecystitis is defined as gallbladder inflammation.
Epidemiology: • Very prevalent. Aetiology • The most common cause is gallstones (calculous cholecystitis). • Acalculous cholecystitis is also seen, particularly in the elderly.
Pathogenesis • Chemical harm to the mucosa by bile is thought to be the cause of biliary stasis. • A gallstone or inadequate gallbladder motility might block the gallbladder exit. Biliary colic causes acute upper abdomen pain that disappears spontaneously after several hours. • Acute cholecystitis is a serious condition characterized by persistent upper abdominal pain, fever, and tachycardia. Macroscopy reveals thicker gallbladder walls and potentially friable mucosa. • Gallstones are often present.
Histopathology • Acute cholecystitis is characterized by oedema, inflammatory cells, and granulation tissue. • Chronic cholecystitis is characterized by muscular hypertrophy and fibrous tissue, mild chronic inflammation, and the development of mucosal diverticula that herniate through the muscular layer (Rokitansky-Aschoff sinuses). • Xanthogranulomatous cholecystitis is a type of chronic cholecystitis characterized by the presence of macrophages and fibroblasts, likely due to a ruptured Rokitansky-Aschoff sinus.
Prognosis: Most individuals with calculous cholecystitis can be treated with cholecystectomy.
- Published on
P
Pathology - Intrahepatic cholangiocarcinoma
A malignant epithelial neoplasm originating in the liver, consisting of cells that resemble bile ducts.
Epidemiology • Uncommon in the majority of populations.
Aetiology Liver flukes (Clonorchis sinensis and Opisthorchis viverrini). • Hepatolithiasis. • PSC • Exposure to Thorotrast, a contrast agent utilized from 1930 until 1955. • Biliary anomalies.
Carcinogenesis • The most prevalent genetic abnormalities are mutations in RAS and TP53.
Presentation • Many manifest late, as they can attain significant size within the liver prior to eliciting symptoms such as malaise, weight loss, and abdominal pain. Tumors infiltrating the hilar area of the liver may manifest as obstructive jaundice.
Macroscopy • The liver has extensive confluent nodules of gray-white tumor, frequently accompanied by satellite deposits. • The surrounding liver tissue is typically non-cirrhotic. Histopathology: Adenocarcinomas characterized by infiltrating malignant epithelial cells that develop glandular and papillary forms. • A characteristic feature is the presence of profuse fibroblastic stroma.
Prognosis: Generally unfavorable, with 5-year survival rates ranging from 40% to 50%, contingent upon the stage.
Pathology - Intrahepatic cholangiocarcinoma
A malignant epithelial neoplasm originating in the liver, consisting of cells that resemble bile ducts.
Epidemiology • Uncommon in the majority of populations.
Aetiology Liver flukes (Clonorchis sinensis and Opisthorchis viverrini). • Hepatolithiasis. • PSC • Exposure to Thorotrast, a contrast agent utilized from 1930 until 1955. • Biliary anomalies.
Carcinogenesis • The most prevalent genetic abnormalities are mutations in RAS and TP53.
Presentation • Many manifest late, as they can attain significant size within the liver prior to eliciting symptoms such as malaise, weight loss, and abdominal pain. Tumors infiltrating the hilar area of the liver may manifest as obstructive jaundice.
Macroscopy • The liver has extensive confluent nodules of gray-white tumor, frequently accompanied by satellite deposits. • The surrounding liver tissue is typically non-cirrhotic. Histopathology: Adenocarcinomas characterized by infiltrating malignant epithelial cells that develop glandular and papillary forms. • A characteristic feature is the presence of profuse fibroblastic stroma.
Prognosis: Generally unfavorable, with 5-year survival rates ranging from 40% to 50%, contingent upon the stage.
- Published on
Pathology - Hepatocellular carcinoma
Definition • A malignant epithelial tumor of the liver originating from hepatocytes.
Epidemiology • Ubiquitous globally, although exhibiting significant geographical diversity. • Incidence rates closely align with HBV infection rates, rendering hepatocellular carcinoma (HCC) especially prevalent in some regions of Africa and Asia.
Etiology
Hepatocellular carcinoma typically develops in the context of liver cirrhosis. Chronic hepatitis B and haemochromatosis are notably carcinogenic substrates. Dietary consumption of aflatoxins produced by Aspergillus fungi is recognized as a strong carcinogen for the liver.
Carcinogenesis • The inactivation of tumor suppressor genes, such as TP53, is prevalent. • Activating mutations of oncogenes seem to be infrequent. The Hepatitis B X gene product impairs p53 functionality and obstructs nucleotide excision repair.
Presentation • Arrives late with nonspecific weight loss and abdominal discomfort. • Established cirrhotics may be identified through the evaluation of an increasing serum alpha-fetoprotein or with ultrasound monitoring.
Macroscopy: Expansile neoplastic tumor in the liver, frequently accompanied by satellite deposits. • The tumor may exhibit a green hue as a result of bile production. • Differentiating tumor deposits from cirrhotic nodules can be challenging.
Histopathology: Classical hepatocellular carcinoma (HCC) consists of epithelial cells akin to hepatocytes, generally proliferating in trabecular formations that resemble thicker hepatic cell plates. The tumor may exhibit bile production. Fibrolamellar HCC is a rare yet unusual form that often occurs in young people without preexisting cirrhosis. Histologically, the tumor consists of clusters of exceptionally large neoplastic cells with plentiful granular pink cytoplasm interspersed with dense fibrous bands.
Prognosis: Generally unfavorable, with 5-year survival rates below 5%. Fibrolamellar hepatocellular carcinoma exhibits a marginally improved prognosis, with 5-year survival rates of 60%.
Definition • A malignant epithelial tumor of the liver originating from hepatocytes.
Epidemiology • Ubiquitous globally, although exhibiting significant geographical diversity. • Incidence rates closely align with HBV infection rates, rendering hepatocellular carcinoma (HCC) especially prevalent in some regions of Africa and Asia.
Etiology
Hepatocellular carcinoma typically develops in the context of liver cirrhosis. Chronic hepatitis B and haemochromatosis are notably carcinogenic substrates. Dietary consumption of aflatoxins produced by Aspergillus fungi is recognized as a strong carcinogen for the liver.
Carcinogenesis • The inactivation of tumor suppressor genes, such as TP53, is prevalent. • Activating mutations of oncogenes seem to be infrequent. The Hepatitis B X gene product impairs p53 functionality and obstructs nucleotide excision repair.
Presentation • Arrives late with nonspecific weight loss and abdominal discomfort. • Established cirrhotics may be identified through the evaluation of an increasing serum alpha-fetoprotein or with ultrasound monitoring.
Macroscopy: Expansile neoplastic tumor in the liver, frequently accompanied by satellite deposits. • The tumor may exhibit a green hue as a result of bile production. • Differentiating tumor deposits from cirrhotic nodules can be challenging.
Histopathology: Classical hepatocellular carcinoma (HCC) consists of epithelial cells akin to hepatocytes, generally proliferating in trabecular formations that resemble thicker hepatic cell plates. The tumor may exhibit bile production. Fibrolamellar HCC is a rare yet unusual form that often occurs in young people without preexisting cirrhosis. Histologically, the tumor consists of clusters of exceptionally large neoplastic cells with plentiful granular pink cytoplasm interspersed with dense fibrous bands.
Prognosis: Generally unfavorable, with 5-year survival rates below 5%. Fibrolamellar hepatocellular carcinoma exhibits a marginally improved prognosis, with 5-year survival rates of 60%.
- Published on
Pathology - Benign hepatic lesions
Hemangioma • The most prevalent neoplasm of the liver. • Macroscopically, well-defined red neoplasms with a spongy texture because to the many vascular structures present inside them.
• Microscopically, it consists of many dilated blood arteries bordered by non-remarkable endothelial cells. • Benign lesions that are typically asymptomatic and necessitate no treatment.
Hepatic adenoma
• Uncommon neoplasm predominantly observed in young women of reproductive age. • Believed to be linked to the utilization of oral contraceptives.
• Macroscopically, single lesions frequently exceed 10 cm in size, exhibiting a softer consistency and a lighter hue compared to the surrounding liver tissue. • Hepatocytes are microscopically organized in plates that are 1 to 3 cells thick. Significant arteries are frequently observed within the lesion; however, portal tracts are lacking. Surgical excision is frequently conducted to avert the potentially lethal consequence of rupture and hemoperitoneum.
Focal nodular hyperplasia
• A benign non-neoplastic lesion typically observed in young women of reproductive age. • Believed to signify a limited region of liver hyperplasia resulting from alterations in blood flow linked to a pre-existing vascular abnormality.
A macroscopically distinct nodular region with a brighter hue than the surrounding liver tissue. Most lesions exhibit a distinctive center scar. •
Microscopic examination reveals nodules of hepatocytes interspersed with fibrous stroma harboring bile ductules. Large, thick-walled jars can serve as a valuable diagnostic indicator. • Harmless and not linked to a risk of hemorrhage.
Biliary hamartoma
• Believed to be a ductal plate deformity. Macroscopically, it presents as a tiny (<5mm) irregular grey lesion of the liver, perhaps multifocal. it consists microscopically tiny ductules situated inside a dense fibrous stroma. concentrated bile may be present within ductules. duct adenoma not constitute genuine tumor, but rather represents reactive proliferation ductular structures.
• Macroscopically, small, firm white lesions, typically larger than biliary hamartomas, often located subcapsularly. • Microscopically, small, uniform ductules that are more densely arranged than those in a biliary hamartoma. Bile is absent in the ductules.
Hemangioma • The most prevalent neoplasm of the liver. • Macroscopically, well-defined red neoplasms with a spongy texture because to the many vascular structures present inside them.
• Microscopically, it consists of many dilated blood arteries bordered by non-remarkable endothelial cells. • Benign lesions that are typically asymptomatic and necessitate no treatment.
Hepatic adenoma
• Uncommon neoplasm predominantly observed in young women of reproductive age. • Believed to be linked to the utilization of oral contraceptives.
• Macroscopically, single lesions frequently exceed 10 cm in size, exhibiting a softer consistency and a lighter hue compared to the surrounding liver tissue. • Hepatocytes are microscopically organized in plates that are 1 to 3 cells thick. Significant arteries are frequently observed within the lesion; however, portal tracts are lacking. Surgical excision is frequently conducted to avert the potentially lethal consequence of rupture and hemoperitoneum.
Focal nodular hyperplasia
• A benign non-neoplastic lesion typically observed in young women of reproductive age. • Believed to signify a limited region of liver hyperplasia resulting from alterations in blood flow linked to a pre-existing vascular abnormality.
A macroscopically distinct nodular region with a brighter hue than the surrounding liver tissue. Most lesions exhibit a distinctive center scar. •
Microscopic examination reveals nodules of hepatocytes interspersed with fibrous stroma harboring bile ductules. Large, thick-walled jars can serve as a valuable diagnostic indicator. • Harmless and not linked to a risk of hemorrhage.
Biliary hamartoma
• Believed to be a ductal plate deformity. Macroscopically, it presents as a tiny (<5mm) irregular grey lesion of the liver, perhaps multifocal. it consists microscopically tiny ductules situated inside a dense fibrous stroma. concentrated bile may be present within ductules. duct adenoma not constitute genuine tumor, but rather represents reactive proliferation ductular structures.
• Macroscopically, small, firm white lesions, typically larger than biliary hamartomas, often located subcapsularly. • Microscopically, small, uniform ductules that are more densely arranged than those in a biliary hamartoma. Bile is absent in the ductules.
- Published on
Pathology - Cirrhosis
Definition • Irreversible substitution of normal liver structure with fibrous tissue bands that segregate nodules of regenerating hepatocytes.
Epidemiology • Prevalent and rising in frequency attributable to alcohol consumption and obesity.
Aetiology
Alcohol, chronic viral hepatitis, and non-alcoholic fatty liver disease (NAFLD) are the predominant etiological factors. • Less frequently, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), Wilson's disease, and hemochromatosis. • In certain instances, the etiology remains ambiguous (cryptogenic cirrhosis).
Pathogenesis
Persistent liver damage prompts Kupffer cells within the vascular sinusoids to secrete cytokines that activate hepatic stellate (Ito) cells. Activated stellate cells undergo proliferation and release substantial amounts of thick collagen, resulting in permanent liver fibrosis and hepatocyte depletion. Cirrhosis induces several functional impairments: diminished synthesis of coagulation factors; decreased glycogen reserves; impaired clearance of pathogens by Kupffer cells; portal hypertension accompanied by hypersplenism and esophageal varices; splanchnic vasodilation; reduced renal blood flow; secondary hyperaldosteronism; and ascites.
Presentation • Atypical symptoms of fatigue and general discomfort. Clinical examination typically reveals signs of chronic liver disease, and liver function tests are generally abnormal. Patients frequently exhibit complications associated with cirrhosis, such as upper gastrointestinal hemorrhage.
Macroscopy • The liver may present as normal in size, hypertrophied, or atrophied. • The sliced surface exhibits a firm texture and displays diffuse nodularity.
Histopathology • The liver is entirely substituted by nodules of regenerating hepatocytes encircled by fibrous bands. • The fibrous bands exhibit a heterogeneous inflammatory infiltrate and reactive bile ductular proliferation. • In certain instances, the characteristics may indicate a specific cause.
Prognosis • Generally unfavorable, with a substantial risk of considerable complications including infections (notably bacterial peritonitis), upper gastrointestinal hemorrhage, renal failure, and hepatocellular cancer.The emergence of comorbidities may lead the patient to terminal liver failure, marked by profound jaundice, significant coagulopathy, hepatic encephalopathy, and an elevated risk of mortality.
Definition • Irreversible substitution of normal liver structure with fibrous tissue bands that segregate nodules of regenerating hepatocytes.
Epidemiology • Prevalent and rising in frequency attributable to alcohol consumption and obesity.
Aetiology
Alcohol, chronic viral hepatitis, and non-alcoholic fatty liver disease (NAFLD) are the predominant etiological factors. • Less frequently, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), Wilson's disease, and hemochromatosis. • In certain instances, the etiology remains ambiguous (cryptogenic cirrhosis).
Pathogenesis
Persistent liver damage prompts Kupffer cells within the vascular sinusoids to secrete cytokines that activate hepatic stellate (Ito) cells. Activated stellate cells undergo proliferation and release substantial amounts of thick collagen, resulting in permanent liver fibrosis and hepatocyte depletion. Cirrhosis induces several functional impairments: diminished synthesis of coagulation factors; decreased glycogen reserves; impaired clearance of pathogens by Kupffer cells; portal hypertension accompanied by hypersplenism and esophageal varices; splanchnic vasodilation; reduced renal blood flow; secondary hyperaldosteronism; and ascites.
Presentation • Atypical symptoms of fatigue and general discomfort. Clinical examination typically reveals signs of chronic liver disease, and liver function tests are generally abnormal. Patients frequently exhibit complications associated with cirrhosis, such as upper gastrointestinal hemorrhage.
Macroscopy • The liver may present as normal in size, hypertrophied, or atrophied. • The sliced surface exhibits a firm texture and displays diffuse nodularity.
Histopathology • The liver is entirely substituted by nodules of regenerating hepatocytes encircled by fibrous bands. • The fibrous bands exhibit a heterogeneous inflammatory infiltrate and reactive bile ductular proliferation. • In certain instances, the characteristics may indicate a specific cause.
Prognosis • Generally unfavorable, with a substantial risk of considerable complications including infections (notably bacterial peritonitis), upper gastrointestinal hemorrhage, renal failure, and hepatocellular cancer.The emergence of comorbidities may lead the patient to terminal liver failure, marked by profound jaundice, significant coagulopathy, hepatic encephalopathy, and an elevated risk of mortality.
- Published on
Pathology - Hereditary hemochromatosis
Definition: An inherited condition marked by heightened intestinal iron absorption, resulting in iron accumulation in several organs, especially the liver, and potentially causing organ damage.
Epidemiology • The genetic incidence of the mutant gene is 0.4% among Caucasian populations, however the clinical penetrance is far lower. • Both males and females are equally affected; however, women typically present later in life due to iron loss associated with menstruation.
Genetics: An autosomal recessive condition resulting from mutations in the HFE gene located on chromosome 6p. • HFE encodes the iron regulating hormone hepcidin. • The most prevalent mutation is a missense mutation at codon 282, resulting in the substitution of a cysteine residue with a tyrosine (C282Y).
Pathogenesis • Hepcidin regulates plasma iron levels by obstructing iron export via ferroportin from duodenal enterocytes and macrophages. • A deficiency in hepcidin leads to elevated plasma iron levels and buildup in several organs, including the liver, pancreas, heart, joints, and pituitary gland
.
Presentation • Initial symptoms are nonspecific and encompass fatigue and arthropathy. • Subsequently, manifestations may include skin pigmentation, cirrhosis, hypogonadism, heart failure, and diabetes mellitus. • If transferrin saturation and serum ferritin levels are elevated, testing for the C282Y mutation should be conducted.
Macroscopy • Advanced instances result in diffuse nodularity attributable to cirrhosis.
Histopathology • The initial histological alteration is the deposition of iron in periportal hepatocytes, as seen by Perl’s stain. As the disease advances, iron accumulates in hepatocytes throughout the liver lobules, accompanied by portal tract enlargement due to fibrosis. • Ultimately, bridging fibrosis ensues, culminating in cirrhosis.
Prognosis: Overall mortality is not elevated in patients who receive prompt diagnosis and appropriate iron depletion therapy. Approximately 5% of men and 1% of women develop cirrhosis. This condition has a poorer prognosis, even with intervention, and poses a substantial risk of hepatocellular carcinoma.
Definition: An inherited condition marked by heightened intestinal iron absorption, resulting in iron accumulation in several organs, especially the liver, and potentially causing organ damage.
Epidemiology • The genetic incidence of the mutant gene is 0.4% among Caucasian populations, however the clinical penetrance is far lower. • Both males and females are equally affected; however, women typically present later in life due to iron loss associated with menstruation.
Genetics: An autosomal recessive condition resulting from mutations in the HFE gene located on chromosome 6p. • HFE encodes the iron regulating hormone hepcidin. • The most prevalent mutation is a missense mutation at codon 282, resulting in the substitution of a cysteine residue with a tyrosine (C282Y).
Pathogenesis • Hepcidin regulates plasma iron levels by obstructing iron export via ferroportin from duodenal enterocytes and macrophages. • A deficiency in hepcidin leads to elevated plasma iron levels and buildup in several organs, including the liver, pancreas, heart, joints, and pituitary gland
.
Presentation • Initial symptoms are nonspecific and encompass fatigue and arthropathy. • Subsequently, manifestations may include skin pigmentation, cirrhosis, hypogonadism, heart failure, and diabetes mellitus. • If transferrin saturation and serum ferritin levels are elevated, testing for the C282Y mutation should be conducted.
Macroscopy • Advanced instances result in diffuse nodularity attributable to cirrhosis.
Histopathology • The initial histological alteration is the deposition of iron in periportal hepatocytes, as seen by Perl’s stain. As the disease advances, iron accumulates in hepatocytes throughout the liver lobules, accompanied by portal tract enlargement due to fibrosis. • Ultimately, bridging fibrosis ensues, culminating in cirrhosis.
Prognosis: Overall mortality is not elevated in patients who receive prompt diagnosis and appropriate iron depletion therapy. Approximately 5% of men and 1% of women develop cirrhosis. This condition has a poorer prognosis, even with intervention, and poses a substantial risk of hepatocellular carcinoma.
- Published on
Pathology - Wilson's disease
Definition: An hereditary disease of copper metabolism resulting in the accumulation of toxic copper levels in the liver and brain. Epidemiology: Rare occurrence. • Although most cases manifest during childhood or young adulthood, the diagnosis should be contemplated as a potential etiology of liver disease at any age. • Both males and females are equally impacted. Genetics: An autosomal recessive condition resulting from mutations in the ATP7B gene, which encodes a copper-transporting ATPase. Approximately 100 distinct mutations have been identified, with the majority of individuals exhibiting compound heterozygosity, meaning they possess two separate mutant alleles.
Pathogenesis • The presence of two mutant ATP7B alleles disrupts normal copper transport, resulting in the accumulation of toxic copper levels in hepatocytes and basal ganglia.
Presentation • The majority of individuals exhibit symptoms in childhood or early adulthood, characterized by chronic liver disease or cirrhosis. • A minority of patients exhibit hepatic failure. • Approximately fifty percent of patients thereafter develop neuropsychiatric symptoms resulting from copper accumulation in the brain, typically following the onset of liver illness.
Macroscopy • At the time of presentation, the majority of patients have advanced disease, and the liver is firm due to significant fibrosis or cirrhosis. Histopathology: Liver biopsies reveal a chronic hepatitis pattern characterized by portal inflammation, dispersed lobular inflammation, and varying degrees of fibrosis, contingent upon the disease stage. The diagnosis is strongly indicated by elevated amounts of stainable copper or copper-associated protein in hepatocytes.
Prognosis • The condition is progressive and culminates in cirrhosis if left untreated. • Continuous administration of metal chelating medicines can avert this progression, if the diagnosis is established promptly. The risk of hepatocellular cancer is minimal.
Definition: An hereditary disease of copper metabolism resulting in the accumulation of toxic copper levels in the liver and brain. Epidemiology: Rare occurrence. • Although most cases manifest during childhood or young adulthood, the diagnosis should be contemplated as a potential etiology of liver disease at any age. • Both males and females are equally impacted. Genetics: An autosomal recessive condition resulting from mutations in the ATP7B gene, which encodes a copper-transporting ATPase. Approximately 100 distinct mutations have been identified, with the majority of individuals exhibiting compound heterozygosity, meaning they possess two separate mutant alleles.
Pathogenesis • The presence of two mutant ATP7B alleles disrupts normal copper transport, resulting in the accumulation of toxic copper levels in hepatocytes and basal ganglia.
Presentation • The majority of individuals exhibit symptoms in childhood or early adulthood, characterized by chronic liver disease or cirrhosis. • A minority of patients exhibit hepatic failure. • Approximately fifty percent of patients thereafter develop neuropsychiatric symptoms resulting from copper accumulation in the brain, typically following the onset of liver illness.
Macroscopy • At the time of presentation, the majority of patients have advanced disease, and the liver is firm due to significant fibrosis or cirrhosis. Histopathology: Liver biopsies reveal a chronic hepatitis pattern characterized by portal inflammation, dispersed lobular inflammation, and varying degrees of fibrosis, contingent upon the disease stage. The diagnosis is strongly indicated by elevated amounts of stainable copper or copper-associated protein in hepatocytes.
Prognosis • The condition is progressive and culminates in cirrhosis if left untreated. • Continuous administration of metal chelating medicines can avert this progression, if the diagnosis is established promptly. The risk of hepatocellular cancer is minimal.
- Published on
Pathology – Non Alcoholic Fatty Liver Disease
• The metabolic syndrome's hepatic manifestation, which includes hyperlipidemia, poor glucose tolerance, and central obesity. Simple steatosis (fatty liver), non-alcoholic steatohepatitis (NASH), and cirrhosis are among the disorders that fall under the umbrella of non-alcoholic fatty liver disease (NAFLD).
Epidemiology: Due to increased obesity rates, this condition is very frequent and is becoming more common. • The most frequent reason for abnormal liver function tests these days. • A large number of cirrhosis cases that were previously believed to be cryptogenic are now believed to be end-stage NAFLD. The cause • The most frequent correlations are between diabetes and obesity. • Also connected to parenteral feeding and some medications.
The pathogenesis • Obesity and insulin resistance appear to be the main contributing factors. • Hepatocyte damage and fat storage are brought on by insulin resistance. • Inflammation in reaction to hepatocyte damage causes fibrosis and, in certain cases, cirrhosis.
Presentation: Abnormal liver function tests are used to identify the majority of asymptomatic cases. • Cirrhosis-related problems can occasionally be seen in patients.
The macroscopy • Cirrhotic livers are diffusely nodular; the liver is swollen, squishy, and greasy.
The study of histopathology • NASH exhibits steatosis together with the presence of enlarged hepatocytes and neutrophils; steatosis is characterized by the buildup of fat within hepatocytes without discernible inflammatory activity. Depending on the disease's stage, there may be variable fibrosis. Keep in mind that these histology results are nearly the same as those observed in alcoholic liver disease. It can occasionally be challenging to rule out alcoholic liver disease since many individuals significantly underreport their alcohol consumption. The outlook • There is extremely little chance that steatosis may develop into chronic liver disease.
• About 10–15% of NASH cases progress to cirrhosis over the course of 8 years. • Compared to individuals with cirrhosis brought on by alcoholic liver disease, those with cirrhosis brought on by nonalcoholic fatty liver disease typically have a higher survival rate.
• The metabolic syndrome's hepatic manifestation, which includes hyperlipidemia, poor glucose tolerance, and central obesity. Simple steatosis (fatty liver), non-alcoholic steatohepatitis (NASH), and cirrhosis are among the disorders that fall under the umbrella of non-alcoholic fatty liver disease (NAFLD).
Epidemiology: Due to increased obesity rates, this condition is very frequent and is becoming more common. • The most frequent reason for abnormal liver function tests these days. • A large number of cirrhosis cases that were previously believed to be cryptogenic are now believed to be end-stage NAFLD. The cause • The most frequent correlations are between diabetes and obesity. • Also connected to parenteral feeding and some medications.
The pathogenesis • Obesity and insulin resistance appear to be the main contributing factors. • Hepatocyte damage and fat storage are brought on by insulin resistance. • Inflammation in reaction to hepatocyte damage causes fibrosis and, in certain cases, cirrhosis.
Presentation: Abnormal liver function tests are used to identify the majority of asymptomatic cases. • Cirrhosis-related problems can occasionally be seen in patients.
The macroscopy • Cirrhotic livers are diffusely nodular; the liver is swollen, squishy, and greasy.
The study of histopathology • NASH exhibits steatosis together with the presence of enlarged hepatocytes and neutrophils; steatosis is characterized by the buildup of fat within hepatocytes without discernible inflammatory activity. Depending on the disease's stage, there may be variable fibrosis. Keep in mind that these histology results are nearly the same as those observed in alcoholic liver disease. It can occasionally be challenging to rule out alcoholic liver disease since many individuals significantly underreport their alcohol consumption. The outlook • There is extremely little chance that steatosis may develop into chronic liver disease.
• About 10–15% of NASH cases progress to cirrhosis over the course of 8 years. • Compared to individuals with cirrhosis brought on by alcoholic liver disease, those with cirrhosis brought on by nonalcoholic fatty liver disease typically have a higher survival rate.
- Published on
Pathology - Primary sclerosing cholangitis
Definition: A chronic hepatic condition marked by inflammation and fibrosis inside the biliary tree. The entire biliary tree is typically involved; but, in some instances, just the small interlobular bile ducts are impacted, known as small duct primary sclerosing cholangitis (PSC).
Epidemiology • Rare occurrence. • Primarily observed in young males with ulcerative colitis (about 70% of patients with primary sclerosing cholangitis also have ulcerative colitis).
Aetiology • Unknown, though a genetic association with specific HLA types exists.
Pathogenesis: Chronic biliary inflammation leads to fibrotic scarring that constricts the afflicted bile ducts. Obstruction in the biliary system results in gradual fibrosis of the liver, culminating in cirrhosis. Biliary stasis additionally facilitates infection and the production of stones.
Presentation • Typically asymptomatic in first stages, but frequently detected through high alkaline phosphatase values in patients with known ulcerative colitis (UC).
Radiology • The presence of strictures and dilations in the biliary tree observed on imaging is strongly indicative of primary sclerosing cholangitis (PSC).
Macroscopy • Initial PSC typically results in no observable macroscopic alterations. Progressive illness results in a cirrhotic liver with bile stains. Fibrotic biliary strictures may be evident in the principal bile ducts.
Histopathology • Explanted liver specimens exhibit fibrosis and inflammation in the major bile ducts, accompanied by thickened bile and calculi. A biliary pattern of cirrhosis is characterized by huge, uneven, jigsaw-like nodules of hepatocytes. Liver biopsy results exhibit varied features based on the biopsy location. If the biopsy is obtained from a region not impacted by the underlying disease, however distal to a significant duct stricture, the liver exhibits characteristics of duct obstruction (i.e., portal edema accompanied by bile ductule growth). If the biopsy is obtained from a region impacted by PSC, medium-sized bile ducts have periductal edema and concentric fibrosis, while small bile ducts are frequently entirely absent.
Prognosis: Progressive hepatic illness ultimately resulting in cirrhosis. Two patients are at elevated risk for bile duct cancer, which occurs in around 20% of cases and is associated with a dismal prognosis.
Definition: A chronic hepatic condition marked by inflammation and fibrosis inside the biliary tree. The entire biliary tree is typically involved; but, in some instances, just the small interlobular bile ducts are impacted, known as small duct primary sclerosing cholangitis (PSC).
Epidemiology • Rare occurrence. • Primarily observed in young males with ulcerative colitis (about 70% of patients with primary sclerosing cholangitis also have ulcerative colitis).
Aetiology • Unknown, though a genetic association with specific HLA types exists.
Pathogenesis: Chronic biliary inflammation leads to fibrotic scarring that constricts the afflicted bile ducts. Obstruction in the biliary system results in gradual fibrosis of the liver, culminating in cirrhosis. Biliary stasis additionally facilitates infection and the production of stones.
Presentation • Typically asymptomatic in first stages, but frequently detected through high alkaline phosphatase values in patients with known ulcerative colitis (UC).
Radiology • The presence of strictures and dilations in the biliary tree observed on imaging is strongly indicative of primary sclerosing cholangitis (PSC).
Macroscopy • Initial PSC typically results in no observable macroscopic alterations. Progressive illness results in a cirrhotic liver with bile stains. Fibrotic biliary strictures may be evident in the principal bile ducts.
Histopathology • Explanted liver specimens exhibit fibrosis and inflammation in the major bile ducts, accompanied by thickened bile and calculi. A biliary pattern of cirrhosis is characterized by huge, uneven, jigsaw-like nodules of hepatocytes. Liver biopsy results exhibit varied features based on the biopsy location. If the biopsy is obtained from a region not impacted by the underlying disease, however distal to a significant duct stricture, the liver exhibits characteristics of duct obstruction (i.e., portal edema accompanied by bile ductule growth). If the biopsy is obtained from a region impacted by PSC, medium-sized bile ducts have periductal edema and concentric fibrosis, while small bile ducts are frequently entirely absent.
Prognosis: Progressive hepatic illness ultimately resulting in cirrhosis. Two patients are at elevated risk for bile duct cancer, which occurs in around 20% of cases and is associated with a dismal prognosis.
